Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1984-12-4
|
pubmed:abstractText |
Age-related macular degeneration (AMD) is one of the four most common causes of blindness in the United States. Retinal manifestations of AMD can be categorized as either atrophic or neovascular/exudative. To the best of our knowledge, the proportion of patients legally blind due to the neovascular/exudative manifestations of this disease has not been previously reported. Data from two studies, the Framingham Eye Study and a large case-control study, demonstrate that the vast majority of patients with legal blindness due to AMD have the neovascular/exudative form of the disease. Seventy-nine percent of eyes legally blind due to AMD in the Framingham population and 90% of eyes legally blind due to AMD in the case-control study had neovascular/exudative retinopathy. This is in spite of the fact that neovascular/exudative retinopathy is a relatively infrequent complication of AMD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0003-9950
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1640-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6208888-Aged,
pubmed-meshheading:6208888-Aging,
pubmed-meshheading:6208888-Blindness,
pubmed-meshheading:6208888-Female,
pubmed-meshheading:6208888-Humans,
pubmed-meshheading:6208888-Laser Therapy,
pubmed-meshheading:6208888-Macula Lutea,
pubmed-meshheading:6208888-Macular Degeneration,
pubmed-meshheading:6208888-Male,
pubmed-meshheading:6208888-Middle Aged,
pubmed-meshheading:6208888-Neovascularization, Pathologic
|
pubmed:year |
1984
|
pubmed:articleTitle |
Age-related macular degeneration and blindness due to neovascular maculopathy.
|
pubmed:publicationType |
Journal Article
|